Prestige Consumer Healthcare Inc. (NYSE:PBH) Expected to Announce Earnings of $1.04 Per Share

Wall Street analysts expect that Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) will announce earnings per share of $1.04 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the highest EPS estimate coming in at $1.05 and the lowest estimate coming in at $1.01. Prestige Consumer Healthcare reported earnings of $1.14 per share during the same quarter last year, which indicates a negative year over year growth rate of 8.8%. The firm is expected to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Prestige Consumer Healthcare will report full year earnings of $4.21 per share for the current fiscal year, with EPS estimates ranging from $4.18 to $4.23. For the next financial year, analysts forecast that the business will report earnings of $4.48 per share, with EPS estimates ranging from $4.45 to $4.50. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that that provide coverage for Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last posted its quarterly earnings results on Thursday, May 5th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. Prestige Consumer Healthcare had a return on equity of 13.82% and a net margin of 18.90%. The business had revenue of $266.94 million for the quarter, compared to analyst estimates of $258.25 million. During the same period last year, the company earned $0.79 EPS. The firm’s revenue was up 12.3% on a year-over-year basis.

Several analysts recently commented on PBH shares. Oppenheimer raised Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 price objective on the stock in a research note on Monday, May 9th. Jefferies Financial Group raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $65.00 to $70.00 in a research note on Tuesday. Finally, StockNews.com started coverage on Prestige Consumer Healthcare in a research note on Thursday, March 31st. They set a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $76.40.

Shares of NYSE:PBH traded up $0.49 during midday trading on Monday, hitting $56.78. The company had a trading volume of 266,318 shares, compared to its average volume of 268,609. Prestige Consumer Healthcare has a 12 month low of $47.81 and a 12 month high of $63.83. The company has a current ratio of 2.04, a quick ratio of 1.21 and a debt-to-equity ratio of 0.94. The stock has a market cap of $2.85 billion, a price-to-earnings ratio of 14.05, a PEG ratio of 1.65 and a beta of 0.58. The firm has a fifty day simple moving average of $54.53 and a 200 day simple moving average of $57.70.

Several institutional investors and hedge funds have recently added to or reduced their stakes in PBH. PNC Financial Services Group Inc. raised its stake in shares of Prestige Consumer Healthcare by 29.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,293 shares of the company’s stock valued at $184,000 after purchasing an additional 754 shares during the period. Swiss National Bank raised its stake in shares of Prestige Consumer Healthcare by 0.4% in the 3rd quarter. Swiss National Bank now owns 110,300 shares of the company’s stock valued at $6,189,000 after purchasing an additional 400 shares during the period. Jennison Associates LLC raised its stake in shares of Prestige Consumer Healthcare by 18.3% in the 3rd quarter. Jennison Associates LLC now owns 442,338 shares of the company’s stock valued at $24,820,000 after purchasing an additional 68,525 shares during the period. Barclays PLC increased its position in shares of Prestige Consumer Healthcare by 107.6% in the third quarter. Barclays PLC now owns 64,759 shares of the company’s stock valued at $3,633,000 after acquiring an additional 33,561 shares during the last quarter. Finally, CIBC Asset Management Inc increased its position in shares of Prestige Consumer Healthcare by 3.7% in the third quarter. CIBC Asset Management Inc now owns 5,848 shares of the company’s stock valued at $328,000 after acquiring an additional 211 shares during the last quarter.

Prestige Consumer Healthcare Company Profile (Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Featured Stories

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.